Ads
related to: tecfidera dosing- Before & After
See Results In Photos Of
Real Patients.
- About Psoriasis
Information On Plaque Psoriasis
& Options Available For Treatment.
- Therapy Information
Alternate Therapy For Plaque
Psoriasis.
- Co-Pay Program
Learn More and See If You Are
Eligible for a Co-Pay Card.
- Patient Resources
Get Tools, Personalized Info,
Talk to a Nurse and More.
- About Plaque Psoriasis
Information On Plaque Psoriasis.
Learn About A Therapy Option.
- Before & After
Search results
Biogen Inc. (BIIB) Down 2.3% Since Last Earnings Report: Can It Rebound?
Zacks via Yahoo Finance· 1 year agoA month has gone by since the last earnings report for Biogen Inc. (BIIB). Shares have lost about...
Why Is Biogen Inc. (BIIB) Up 8.2% Since Last Earnings Report?
Zacks via Yahoo Finance· 2 years agoA month has gone by since the last earnings report for Biogen Inc. (BIIB). Shares have added about...
Biotech Stock Roundup: BIIB's Q1 Results, ARWR Up on Data, INCY & BLUE Offer Updates
Zacks via Yahoo Finance· 1 year agoThe biotech sector has been in focus in the past week with key pipeline and regulatory updates....
Biotech Stock Roundup: BIIB's Q4 Results, EBS and BPMC Offer Updates
Zacks via Yahoo Finance· 1 year agoThe biotech sector was in the spotlight with fourth-quarter results. Other pipeline and regulatory...
Biotech Stock Roundup: BIIB, GSK's Q2 Earnings, KOD Faces Setback & More
Zacks via Yahoo Finance· 10 months agoIt was a busy week for the biotech sector, with a focus on earnings and important regulatory and...
Is Biogen a Smart Biotech Stock to Buy Right Now?
Motley Fool· 2 years agoTens of millions of Alzheimer's disease patients were given a rare dose of good news recently when Biogen (NASDAQ: BIIB) released some encouraging...
Biogen Inc. (NASDAQ:BIIB) Q4 2022 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 year agoBiogen Inc. (NASDAQ:BIIB) Q4 2022 Earnings Call Transcript February 15, 2023 Operator: Good morning....
Novartis' (NVS) Sandoz Gets FDA Nod for Tysabri's Biosimilar
Zacks via Yahoo Finance· 9 months agoNovartis’ NVS generic arm, Sandoz, announced that the FDA approved Tyruko (natalizumab-sztn), a...
Biotech Stock Roundup: BMY, BIIB's Q2 Earnings, GILD's Updates & More
Zacks via Yahoo Finance· 2 years agoThe biotech sector has been in the spotlight in the past week on earnings releases. Other pipeline...
What Is the First Line of Treatment for Multiple Sclerosis?
Verywell Health via Yahoo News· 2 years agoMedically reviewed by Lindsay Cook, PharmD In multiple sclerosis (MS), the immune system attacks the...
Ads
related to: tecfidera dosing